Philip Morris Can Market Zyn Pouches as Safer Than Smoking

Philip Morris International (PMI) received approval this week to market its Zyn nicotine pouches in the United States, a significant development in the company's strategy to transition away from traditional combustible cigarettes. The U.S. Food and Drug Administration (FDA) granted Premarket Tobacco Product Applications (PMTAs) for Zyn, allowing the company to continue selling the product and to market it as a reduced-risk alternative to smoking.

This approval signifies a shift in the tobacco industry's landscape, with companies increasingly focusing on reduced-risk products (RRPs) to capture market share and address evolving consumer preferences and regulatory pressures. Zyn, a Swedish-manufactured oral nicotine pouch, has seen substantial growth in the U.S. market, driven by consumers seeking alternatives to smoking and vaping. PMI acquired Swedish Match, the original maker of Zyn, in 2022 for $16 billion, a move that underscored the company's commitment to expanding its presence in the smoke-free category.

The FDA's decision to grant PMTAs for Zyn means the agency has determined that marketing these products is appropriate for the protection of public health, considering both the risks and benefits to the population as a whole. This contrasts with the agency's stance on other nicotine products, highlighting a nuanced regulatory approach to different forms of nicotine delivery. Philip Morris International has stated its intention to invest further in its smoke-free portfolio, with Zyn positioned as a key driver of future growth.

Philip Morris International's CEO, Jacek Olczak, has previously emphasized the company's ambition to generate the majority of its revenue from smoke-free products by 2030. The approval of Zyn's PMTAs is a crucial step towards achieving this goal, enabling the company to leverage the product's popularity and market it with a reduced-risk claim. This regulatory milestone is expected to intensify competition within the rapidly expanding oral nicotine pouch market.